EGM
PRME icon

Engineers Gate Manager’s Prime Medicine PRME Stock Holding History

Engineers Gate Manager’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$218K Sell
59,133
-51,215
-46% -$170K ﹤0.01% 1924
2026
Q1 		$384K Buy
110,348
+49,858
+82% +$190K ﹤0.01% 1566
2025
Q4 		$210K Buy
60,490
+4,893
+9% +$21.8K ﹤0.01% 1784
2025
Q3 		$308K Buy
+55,597
New +$226K ﹤0.01% 1738

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Engineers Gate Manager's PRME Position: Q2 2026 in Review

Engineers Gate Manager reduced its Prime Medicine (PRME) stake by 46% in Q2 2026, selling an estimated $170K and leaving 59,133 shares worth $218K. The position accounts for ﹤0.01% of the portfolio, ranked #1924.

Engineers Gate Manager first reported a position in PRME in Q3 2025 and has held it in 4 quarters since. The position peaked at $384K in Q1 2026. 188 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • Engineers Gate Manager held 59,133 shares of Prime Medicine worth $218K as of Q2 2026.
  • Engineers Gate Manager sold 51,215 Prime Medicine shares in Q2 2026, an estimated $170K.
  • Prime Medicine made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #1924 holding.
  • Engineers Gate Manager first reported a position in Prime Medicine in Q3 2025 and has held it in 4 quarters since.
  • Engineers Gate Manager's Prime Medicine position peaked at $384K in Q1 2026.
  • 188 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.